Literature DB >> 12444595

Transgenic zebrafish model of neurodegeneration.

Henry G Tomasiewicz1, Denise B Flaherty, J P Soria, John G Wood.   

Abstract

In Alzheimer's disease (AD), the microtubule-associated protein, tau, is compromised in its normal association with microtubules and forms into paired helical filaments (PHF) that are the hallmark cytoskeletal pathology of the disease. Several posttranslational modifications of tau including phosphorylation have been implicated in AD pathogenesis. In addition, and importantly, mutations in the genes encoding human tau have recently been implicated in a variety of hereditary dementias, collectively termed frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). This has rekindled interest in the importance of tau in neurodegenerative diseases (cf. Vogel [1998] Science 280:1524-1525; Goedert et al. [1998] Neuron 21:955-958; D'Souza et al. [1999] PNAS 96:5598-5603). Despite significant progress in the field of tau biology and neurodegenerative diseases, several important issues remain unresolved. The early functional consequences of tau alterations in living neurons is incompletely understood, and it is not clear how tau in neurodegenerative diseases becomes redistributed from its normal concentration in neuronal axons to pathological inclusions in neuronal soma known as neurofibrillary tangles (NFT). One of the reasons for these gaps in knowledge is the relative paucity of model systems to study these processes. We have developed a transgenic model system to study the functional consequences and trafficking patterns in zebrafish neurons of human tau either mutated on sites associated with hereditary dementias or altered at select posttranslational modification sites. The overall guiding hypothesis is that the model allows dissection of a hierarchy of events relevant to potential mechanisms of neurodegenerative diseases related to critical early stages in development of disease. We showed that a FTDP-17 mutant form of human tau expressed in zebrafish neurons produced a cytoskeletal disruption that closely resembled the NFT in human disease. This model system will prove useful in the study of other mutant taus in vertebrate neurons in vivo, and the approaches developed here will have broad usefulness in the study of functional consequences and potential genetic analyses of introducing into living vertebrate neurons other molecules involved in the pathogenesis of neurodegenerative diseases. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444595     DOI: 10.1002/jnr.10451

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 2.  Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics.

Authors:  David T White; Meera T Saxena; Jeff S Mumm
Journal:  Adv Drug Deliv Rev       Date:  2019-02-12       Impact factor: 15.470

Review 3.  Zebrafish models of Tauopathy.

Authors:  Qing Bai; Edward A Burton
Journal:  Biochim Biophys Acta       Date:  2010-09-16

4.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

5.  Using zebrafish to assess the impact of drugs on neural development and function.

Authors:  Su Guo
Journal:  Expert Opin Drug Discov       Date:  2009-07-01       Impact factor: 6.098

Review 6.  Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Authors:  Adam L Boxer; Michael Gold; Edward Huey; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven Khachaturian; Margaret Sutherland; Robert Farese; Bruce L Miller; Jeffrey Cummings
Journal:  Alzheimers Dement       Date:  2012-10-05       Impact factor: 21.566

7.  Generation and characterization of transgenic zebrafish lines using different ubiquitous promoters.

Authors:  Christopher T Burket; Jacob E Montgomery; Ryan Thummel; Sean C Kassen; Matthew C LaFave; David M Langenau; Leonard I Zon; David R Hyde
Journal:  Transgenic Res       Date:  2007-10-30       Impact factor: 2.788

8.  A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation.

Authors:  Dominik Paquet; Ratan Bhat; Astrid Sydow; Eva-Maria Mandelkow; Stefan Berg; Sven Hellberg; Johanna Fälting; Martin Distel; Reinhard W Köster; Bettina Schmid; Christian Haass
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

Review 9.  Zebrafish Models to Study New Pathways in Tauopathies.

Authors:  Clément Barbereau; Nicolas Cubedo; Tangui Maurice; Mireille Rossel
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

10.  The developing utility of zebrafish models for cognitive enhancers research.

Authors:  Adam Michael Stewart; Allan V Kalueff
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.